loader
Please Wait
Applying Filters...

Information, Expiry & Status of Health Canada Patents covering Gefitinib.

Menu
$ API Ref.Price (USD/KG) : 1,750Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2AstraZeneca Canada Inc.

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Luxepack
Not Confirmed
arrow
Luxepack
Not Confirmed

Gefitinib

Brand Name : IRESSA

Patent Number : 2215732

Filing Date : 1996-04-23

Strength per Unit : 250 mg

Dosage Form : Film-Coated Tablets

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2016-04-23

Date Granted : 2002-04-09

blank

02

arrow
Luxepack
Not Confirmed
arrow
Luxepack
Not Confirmed

Gefitinib

Brand Name : IRESSA

Patent Number : 2086968

Filing Date : 1993-01-08

Strength per Unit : 250 mg

Dosage Form : Film-Coated Tablets

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2013-01-08

Date Granted : 1998-06-23

blank